Literature DB >> 22284438

Contribution of active site glutamine to rate enhancement in ubiquitin C-terminal hydrolases.

David A Boudreaux1, Joseph Chaney, Tushar K Maiti, Chittaranjan Das.   

Abstract

Ubiquitin C-terminal hydrolases (UCHs) are cysteine proteases featuring a classical Cys-His-Asp catalytic triad, and also a highly conserved Gln that is thought to be a part of the oxyanion hole. However, the contribution of this side chain to catalysis by UCHs is not known. Herein, we demonstrate that the Gln side chain contributes to rate enhancement in UCHL1, UCHL3, and UCHL5. Mutation of the Gln to Ala in these enzymes impairs the catalytic efficiency, mainly because of a 16-fold to 30-fold reduction in k(cat) , which is consistent with a loss of approximately 2 kcal·mol(-1) in transition state stabilization. However, the contribution to transition state stabilization observed here is rather modest for the side chain's role in oxyanion stabilization. Interestingly, we discovered that the carbonyl oxygen of this side chain is engaged in a C-H···O hydrogen-bonding contact with the CεH group of the catalytic His. Upon further analysis, we found that this interaction is a common active site structural feature in most cysteine proteases, including papain, belonging to families with the QCH(N/D) type of active site configuration. It is possible that removal of the Gln side chain might have abolished the C-H···O interaction, which typically accounts for 2 kcal·mol(-1) of stabilization, leading to the effect on catalysis observed here. Additional studies performed on UCHL3 by mutating the Gln to Glu (strong C-H···O acceptor but oxyanion destabilizer) and to Lys (strong oxyanion stabilizer but lacking C-H···O hydrogen-bonding capability) suggest that the C-H···O hydrogen bond could contribute to catalysis.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22284438      PMCID: PMC3410986          DOI: 10.1111/j.1742-4658.2012.08507.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  34 in total

1.  Structural basis for the specificity of ubiquitin C-terminal hydrolases.

Authors:  S C Johnston; S M Riddle; R E Cohen; C P Hill
Journal:  EMBO J       Date:  1999-07-15       Impact factor: 11.598

2.  The Calpha ---H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions.

Authors:  A Senes; I Ubarretxena-Belandia; D M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  A C-H triplebond O hydrogen bond stabilized polypeptide chain reversal motif at the C terminus of helices in proteins.

Authors:  M Madan Babu; S Kumar Singh; P Balaram
Journal:  J Mol Biol       Date:  2002-09-27       Impact factor: 5.469

Review 4.  Mechanisms, biology and inhibitors of deubiquitinating enzymes.

Authors:  Kerry Routenberg Love; André Catic; Christian Schlieker; Hidde L Ploegh
Journal:  Nat Chem Biol       Date:  2007-11       Impact factor: 15.040

5.  Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1.

Authors:  Chittaranjan Das; Quyen Q Hoang; Cheryl A Kreinbring; Sarah J Luchansky; Robin K Meray; Soumya S Ray; Peter T Lansbury; Dagmar Ringe; Gregory A Petsko
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 6.  DUBs at a glance.

Authors:  Keith D Wilkinson
Journal:  J Cell Sci       Date:  2009-07-15       Impact factor: 5.285

7.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

8.  Dissecting the paradoxical effects of hydrogen bond mutations in the ketosteroid isomerase oxyanion hole.

Authors:  Daniel A Kraut; Paul A Sigala; Timothy D Fenn; Daniel Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

9.  Mechanistic studies of ubiquitin C-terminal hydrolase L1.

Authors:  April Case; Ross L Stein
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

10.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21
View more
  4 in total

1.  The Two Deubiquitinating Enzymes from Chlamydia trachomatis Have Distinct Ubiquitin Recognition Properties.

Authors:  John M Hausman; Sebastian Kenny; Shalini Iyer; Aditya Babar; Jiazhang Qiu; Jiaqi Fu; Zhao-Qing Luo; Chittaranjan Das
Journal:  Biochemistry       Date:  2020-04-14       Impact factor: 3.162

2.  Stabilization of an unusual salt bridge in ubiquitin by the extra C-terminal domain of the proteasome-associated deubiquitinase UCH37 as a mechanism of its exo specificity.

Authors:  Marie E Morrow; Myung-Il Kim; Judith A Ronau; Michael J Sheedlo; Rhiannon R White; Joseph Chaney; Lake N Paul; Markus A Lill; Katerina Artavanis-Tsakonas; Chittaranjan Das
Journal:  Biochemistry       Date:  2013-05-09       Impact factor: 3.162

3.  Insights into Ubiquitin Product Release in Hydrolysis Catalyzed by the Bacterial Deubiquitinase SdeA.

Authors:  Michael J Sheedlo; Sebastian Kenny; Ivan S Podkorytov; Kwame Brown; Jia Ma; Shalini Iyer; Chad S Hewitt; Trent Arbough; Oleg Mikhailovskii; Daniel P Flaherty; Mark A Wilson; Nikolai R Skrynnikov; Chittaranjan Das
Journal:  Biochemistry       Date:  2021-02-14       Impact factor: 3.162

4.  Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome.

Authors:  Yun-Tzai Cloud Lee; Chia-Yun Chang; Szu-Yu Chen; Yun-Ru Pan; Meng-Ru Ho; Shang-Te Danny Hsu
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.